Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Marina Gasparini is active.

Publication


Featured researches published by Marina Gasparini.


Journal of Neurology | 2001

Frontal lobe dysfunction in essential tremor: a preliminary study.

Marina Gasparini; Vincenzo Bonifati; Edito Fabrizio; Giovanni Fabbrini; Livia Brusa; Gian Luigi Lenzi; Giuseppe Meco

Abstract 27 patients with essential tremor (ET) were studied to determine the cognitive feature of this condition. 15 familial cases and 12 cases with a family history Parkinsons disease (PD) were identified. Performances on frontal lobe tasks of ET patients were compared with those of 15 patients with PD and 15 healthy control subjects. The ET patients showed significant impairments both in attentional and conceptual thinking tasks, similar to those observed in the PD group. Despite the nosographic independence of the two conditions, data showed that the frontal lobe feature of ET was similar to those of PD, thus possibly suggesting a common dysregulation of dopamine pathways.


Neurology | 2003

Neuropsychiatric lupus syndromes: relationship with antiphospholipid antibodies.

Antonella Afeltra; Pierluigi Garzia; Anna Paola Mitterhofer; Marta Vadacca; Sara Galluzzo; Flavia Del Porto; Licia Finamore; Stefano Pascucci; Marina Gasparini; Bruno Laganà; Domenico Caccavo; Giovanni Maria Ferri; A. Amoroso; Ada Francia

The authors assessed the prevalence of neuropsychiatric manifestations occurring in patients with systemic lupus erythematosus (NPSLE), according to the American College of Rheumatology standardized definitions for NPSLE, and evaluated the relationship between NPSLE and antiphospholipid antibodies. Sixty-one consecutive SLE patients were studied. Neuropsychiatric manifestations consistent with the diagnosis of NPSLE occurred in 44 (72%). Patients with NPSLE showed significantly higher levels of anticardiolipin antibodies.


Neurological Sciences | 2002

A case-control study on Alzheimer's disease and exposure to anesthesia.

Marina Gasparini; Nicola Vanacore; C. Schiaffini; L. Brusa; M. Panella; Giuseppina Talarico; Giuseppe Bruno; Giuseppe Meco; G. L. Lenzi

A retrospective hospital-based case-control study was performed with the aim to evaluate the association between exposure to anesthesia and Alzheimer’s disease (AD). A total of 115 AD patients, 230 Parkinson’s disease (PD) patients and 230 patients with non-degenerative neurological disease were studied. Each AD case was matched for sex, age (±3 years) and geographic area of residence with four controls (2 PD patients and 2 with other neurological disease). Information about exposure to general anesthesia and other variables was gathered through hospital records. No associations were found between the risk of AD and the exposure to anesthesia in the 1 and 5 years preceding disease onset, nor between the risk of AD and the number of surgical operations. A significant difference was observed between the mean age of AD patients and controls undergoing surgical procedures. The present study reveals a lack of association between exposure to general anesthesia and AD. Prospective epidemiological studies are needed in order to investigate levels of exposure to anesthesia, as well as any possible relationships between anesthetic exposure and genetic factors (e. g. APOEɛ4 genotype).


Journal of Neural Transmission | 1997

Cognitive improvement during Tolcapone treatment in Parkinson's disease

Marina Gasparini; Edito Fabrizio; Vincenzo Bonifati; Giuseppe Meco

SummaryThe aim of this study was to evaluate the effects of Tolcapone, a reversible, selective inhibitor of catechol-O-methyltransferase, on the cognitive functions of eight patients with advanced Parkinsons disease. They underwent neuropsychological and motor assessment at baseline and were reevaluated after 6 months. During this period, they received Tolcapone three times daily, while the L-dopa dosage was progressively reduced. Significant improvements were observed in the attentional task, auditory verbal short-term memory, visuo-spatial recall, constructional praxia and motor symptoms. These data suggest that treatment with Tolcapone, in combination with L-dopa therapy, may determine a significant improvement in cognitive resources of patients with advanced Parkinsons disease.


Neurology | 2004

Delayed poststroke dementia: A 4-year follow-up study

Marta Altieri; V. Di Piero; Marta Pasquini; Marina Gasparini; Nicola Vanacore; Edoardo Vicenzini; G. L. Lenzi

Objective: To assess patients who have had a stroke for the subsequent development of poststroke dementia (PSD) and to determine if the characteristics of delayed PSD (dPSD) vary in the long-term follow-up. Methods: Nondemented patients were followed from 6 months after stroke onset for 4 years. Dementia was diagnosed by International Classification of Diseases-10 criteria; dementia etiology was diagnosed by the National Institute of Neurological and Communication Disorders and Stroke/Alzheimer’s Disease and Related Disorders Association and National Institute of Neurologic Disorders and Stroke/Association Internationale pour la Recherche et l’Enseignement en Neurosciences criteria. Neuroimaging and neuropsychological tests were repeated annually. Results: During a 2-year period, 191 stroke patients were enrolled. By the end of the follow-up period, 41 (21.5%) patients had developed dementia. At the Cox regression analysis, dPSD was associated with cortical atrophy (hazard ratio [HR] = 3.4, 95% CI 1.5 to 7.9), age (HR = 3.3, 95% CI 1.4 to 7.8), and multiple ischemic lesions (HR = 2.5, 95% CI 1.2 to 4.8). The Kaplan-Meier analysis showed a significant difference between the incidence of dPSD subtypes (log-rank test; p = 0.002). Conclusions: During the 4-year follow-up, the incidence of dementia increased gradually, shifting from an Alzheimer disease-type picture in the first years to a vascular dementia type later in years 2 to 4.


Acta Neurologica Scandinavica | 2001

Donepezil in the treatment of progressive supranuclear palsy

Giovanni Fabbrini; Piero Barbanti; Vincenzo Bonifati; Carlo Colosimo; Marina Gasparini; Nicola Vanacore; Giuseppe Meco

Objectives– To evaluate the effect of 3 month therapy with donepezil, a centrally acting cholinesterase inhibitor, on cognitive performances, motor function and daily living activities in progressive supranuclear palsy (PSP). Materials and methods– Six patients with a diagnosis of PSP were evaluated at baseline and after 3 months of treatment with donepezil, 10 mg given at bedtime. Cognitive functions, motor symptoms and daily activities were evaluated by means of appropriate rating scales. Results– Donepezil was not effective on cognitive dysfunction and did not change ratings of daily living. Parkinsonian symptoms were unaffected by donepezil treatment. Conclusions– Cholinergic replacement therapy alone is not likely to improve symptoms in a disorder characterized by a more widespread impairment of monoaminergic systems. Larger studies may be necessary to confirm the lack of effect of donepezil in this disorder.


Journal of Neurology, Neurosurgery, and Psychiatry | 1996

Attentional functions in multiple system atrophy and Parkinson's disease

Giuseppe Meco; Marina Gasparini; Fabrizio Doricchi

OBJECTIVE: To assess cognitive performances of patients with striatonigral degeneration type multiple system atrophy compared with those of patients with Parkinsons disease. METHODS: The cognitive performances of a group of patients with multiple system atrophy of the striatonigral type were compared with those of matched patients with Parkinsons disease and controls, using tests sensitive to frontal lobe dysfunction. RESULTS: The multiple system atrophy group, when compared with the Parkinsons disease group, showed significant deficits in attention tasks, particularly in the Stroop test. CONCLUSION: There was a consistently greater impairment in attention resources in patients with multiple system atrophy than in patients with Parkinsons disease.


Current Biology | 2009

Spatial orienting biases in the decimal numeral system.

Fabrizio Doricchi; Sheila Merola; Marilena Aiello; Paola Guariglia; Michela Bruschini; Wim Gevers; Marina Gasparini; Francesco Tomaiuolo

Humans map numbers upon a mental number line (MNL) on which small integers are placed to the left of larger ones [1-9]. Here, we show that human adults systematically shift the subjective midpoints of number intervals away from the borders separating contiguous tens along the MNL. Number intervals are erroneously bisected further to the right the closer they are to the left starting point of the tens and further to the left the closer they are to the right endpoint of the tens. Similarly, right-brain-damaged patients neglecting the left side of the MNL [10-12] show enhanced pathological rightward deviation in the bisection of number intervals located toward the left starting point of the tens and reduced deviation for intervals located toward the right endpoint of the tens. These data disclose the effects that the recursive grouping of symbolic decimal numerals within the tens has brought on the phylogenetically and ontogenetically foregoing spatial representation of magnitudes [13-16].


Neurological Sciences | 2002

Evaluation of risk of Parkinson's disease in a cohort of licensed pesticide users.

Nicola Vanacore; A. Nappo; M Gentile; A. Brustolin; S. Palange; A. Liberati; S. Di Rezze; G. Caldora; Marina Gasparini; F. Benedetti; Vincenzo Bonifati; F. Forastiere; A. Quercia; Giuseppe Meco

Abstract. In the last two years, the environmental theory on the aetiology of Parkinson disease has acquired new data. From an experimental point of view, a new model of parkinsonism induced by rotenone, a diffuse insecticide, has been proposed, and in vitro studies have provided proof that several pesticides stimulate the formation of α-synuclein fibrils (one of the principal constituents of Lewy bodies). Moreover, a meta-analysis of all case-control studies so far performed showed a positive, statistically significant association between pesticide exposure and PD. In this context, we are performing a cohort study on 5575 licensed pesticide users in the province of Viterbo. After 27 years of follow-up, 4788 subjects are still alive. The aim of this study is to measure the prevalence of Parkinsons disease in a large group of workers with theoretically increased risk.


American Journal of Alzheimers Disease and Other Dementias | 2013

Restless legs syndrome in a group of patients with Alzheimer's disease.

Giuseppina Talarico; Marco Canevelli; Giuseppe Tosto; Nicola Vanacore; Federica Letteri; M. Prastaro; Fernanda Troili; Marina Gasparini; Gian Luigi Lenzi; Giuseppe Bruno

Background: Restless legs syndrome (RLS) is a neurological disorder characterized by the urge to move the legs associated with peculiar unpleasant sensations during periods of rest and inactivity that are relieved by movement. A few studies analyzed RLS in neurodegenerative diseases such as Alzheimers Disease (AD). The aim of our study was to assess the prevalence and the clinical characteristics of RLS in a cohort of AD patients. Methods: Three hundred and thirty-nine subjects with a diagnosis of AD were recruited. Cognitive, functional, and neuropsychiatric measures were collected at baseline and six-monthly for a 2-years follow-up Results: Fourteen subjects met the RLS criteria. RLS subjects were more frequently male (p:0,006) and younger than AD subject without RLS (p:0,029). MMSE, ADL and IADL were not significantly different. NPI total scores did not differ significantly, however, AD patients with RLS were found to be more apathetic (p:0,001) than AD subjects without RLS. Conclusion: RLS prevalence in our AD cohort was estimated to be about 4%. RLS appeared to be associated with neuropsychiatric symptoms such as apathy. RLS and apathy might share a common pathophysiological basis represented by a dysfunction of the central dopaminergic system

Collaboration


Dive into the Marina Gasparini's collaboration.

Top Co-Authors

Avatar

Giuseppe Bruno

Sapienza University of Rome

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Nicola Vanacore

Istituto Superiore di Sanità

View shared research outputs
Top Co-Authors

Avatar

Annamaria Confaloni

Istituto Superiore di Sanità

View shared research outputs
Top Co-Authors

Avatar

Gian Luigi Lenzi

Sapienza University of Rome

View shared research outputs
Top Co-Authors

Avatar

Paola Piscopo

Istituto Superiore di Sanità

View shared research outputs
Top Co-Authors

Avatar

Alessio Crestini

Istituto Superiore di Sanità

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Giuseppe Meco

Sapienza University of Rome

View shared research outputs
Top Co-Authors

Avatar

Marco Canevelli

Sapienza University of Rome

View shared research outputs
Researchain Logo
Decentralizing Knowledge